Pharmacokinetics and Pharmacodynamics Study of Bivalirudin in Healthy Chinese Adult Subjects

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-OO-13003478

Enrollment

Unknown

Registered

2013-07-09

Start date

2007-09-15

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

percutaneous transluminal coronary angioplasty

Interventions

group 2:0.5mg/kg

group1:0.25mg/kg

group 3:0.75mg/kg

Eligibility

Sex/Gender

All

Age

18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Subjects 18 to 40 years of age written informed consent. The scope of subjects BMI is 18~25 kg/m2.

Exclusion criteria

Exclusion criteria: Pregnancy, lactation, menstruation, ready for pregnant women. Important organs of primary disease. Drug or alcohol dependence or suspicion.

Design outcomes

Primary

Measure	Time frame
drug concentration;	—

Secondary

Measure	Time frame
APTT;PT;	—

Countries

China

Contacts

Public Contactyuhong huang

hyh101@126.com+86 022 60335308

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026